Fixed‐dose combination therapy for the prevention of atherosclerotic cardiovascular diseases

E Bahiru, AN De Cates, MRB Farr… - Cochrane Database …, 2017 - cochranelibrary.com
Background Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death
and disability worldwide, yet ASCVD risk factor control and secondary prevention rates …

Recent Advances in Pyridine‐Based Organocatalysis and its Application towards Valuable Chemical Transformations

R Gujjarappa, N Vodnala, CC Malakar - ChemistrySelect, 2020 - Wiley Online Library
The role of pyridine scaffolds in the field of synthetic organic and medicinal chemistry is
impeccable and irreplaceable due to its wide spectrum of applications. Pyridines are well …

Formulations of amlodipine: a review

MA Sheraz, SF Ahsan, MF Khan… - Journal of …, 2016 - Wiley Online Library
Amlodipine (AD) is a calcium channel blocker that is mainly used in the treatment of
hypertension and angina. However, latest findings have revealed that its efficacy is not only …

Effect and mechanism of HMG-CoA reductase inhibitor on the improvement of elderly essential hypertension-induced vascular endothelial function impairment based …

W Yuan, H Fan, H Yang, L Tang, Z Liu, F Ouyang… - Diagnostic …, 2023 - Springer
Objective Our research was designed to figure out the influence and mechanism of 3-
hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor on the improvement of …

Triple combination therapy for global cardiovascular risk: atorvastatin, perindopril, and amlodipine

ME Bertrand, C Vlachopoulos, JJ Mourad - American Journal of …, 2016 - Springer
Statins, angiotensin-converting enzyme (ACE) inhibitors, and calcium channel blockers
(CCBs) have markedly changed the clinical progression of patients with coronary artery …

[PDF][PDF] Комбинация амлодипина и аторвастатина в снижении риска кардиоваскулярных осложнений

Д Дедов, Н Мукаилов, И Евтюхин - Врач, 2013 - pharmaco.rusvrach.ru
Рассматриваются вопросы применения фиксированной комбинации амлодипин/
аторвастатин у больных артериальной гипертензией и ишемической болезнью сердца …

Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension

MS Zhou, R Tian, EA Jaimes… - American journal of …, 2014 - academic.oup.com
BACKGROUND Current treatment for the secondary prevention of cardiovascular diseases
frequently involves the prescription of several combination therapies, particularly …

[PDF][PDF] 氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的临床疗效[J]

陈爱华 - 实用心脑肺血管病杂志, 2014 - boyuancaibian.oss-cn-beijing …
目的观察氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的临床疗效. 方法选择我院2013 年2
月—2014 年2 月收治的高血压合并冠心病患者120 例, 采用抽签方式随机分为观察组和对照组 …

Pharmacokinetic Interaction Between Amlodipine and Lobeglitazone, a Novel Peroxisome Proliferator–activated Receptor-γ Agonist, in Healthy Subjects

COK Kim, ES Oh, C Kim, MS Park - Clinical Therapeutics, 2015 - Elsevier
Purpose Lobeglitazone, a peroxisome proliferator–activated receptor-γ agonist, was
developed for the treatment of diabetes mellitus. Because the prevalence of hypertension is …

Nano-catalyzed synthesis of pyranopyrazole and pyridine scaffolds

AP Katariya, AK Dhas, AB Kanagare… - Nanoparticles in Green …, 2023 - Elsevier
Herein we summarized the application of nanoscience and nanotechnologies fostering the
attention of technologists due to their huge potential to benefit many fields of research and …